This book provides a comprehensive and state-of-the-art overview of benefit-risk assessment methods in drug development. Unlike other books which focus mainly on qualitative benefit-risk assessments,
This edited volume is a definitive text on adaptive clinical trial designs from creation and customization to utilization. As this book covers the full spectrum of topics involved in the adaptive desi
